Nutritional management of chronic kidney disease

New England Journal of Medicine

Volumn 377, Issue 18, 2017, Pages 1765-1776

  Kalantar Zadeh, Kamyar ^a,b,c,d,e   Fouque, Denis ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Transportation Research Institute   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM ACETATE; CITRATE CALCIUM; COLECALCIFEROL; ENALAPRIL; ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; FOLIC ACID; LOOP DIURETIC AGENT; PHOSPHORUS; PROBIOTIC AGENT; TRACE ELEMENT; UREMIC TOXIN; VITAMIN;

CALCIUM ABSORPTION; CALCIUM INTAKE; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; DIETARY COMPLIANCE; DIETARY FIBER; ESTIMATED GLOMERULAR FILTRATION RATE; FAT INTAKE; FLUID RETENTION; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; HYPONATREMIA; INTESTINE FLORA; METABOLIC ACIDOSIS; NONHUMAN; NUTRITION; NUTRITION EDUCATION; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; PROTEIN RESTRICTION; PROTEINURIA; REVIEW; SECONDARY HYPERPARATHYROIDISM; SODIUM RESTRICTION; UREMIA; URINALYSIS; VEGETARIAN DIET; ACIDOSIS; ADULT; COMPLICATION; DIET THERAPY; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY;

ACIDOSIS; ADULT; DIET, PROTEIN-RESTRICTED; DIET, SODIUM-RESTRICTED; HUMANS; NUTRITIONAL REQUIREMENTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 85032732157     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1700312     Document Type: Review

References (82)

1. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
2. Armstrong JE, Laing DG, Wilkes FJ, Kainer G. Smell and taste function in children with chronic kidney disease. Pediatr Nephrol 2010;25:1497-504.
3. Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol 2013; 37:1-6.
4. Bello AK, Levin A, Tonelli M, et al. Assessment of global kidney health care status. JAMA 2017;317:1864-81.
5. Hostetter TH, Meyer TW, Rennke HG, Brenner BM. Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986;30:509-17.
6. Tovar-Palacio C, Tovar AR, Torres N, et al. Proinflammatory gene expression and renal lipogenesis are modulated by dietary protein content in obese Zucker fa/fa rats. Am J Physiol Renal Physiol 2011;300:F263-F271.
7. Brenner BM, Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol Suppl (Copenh) 1981;242:7-10.
8. Wrone EM, Carnethon MR, Palaniappan L, Fortmann SP. Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:580-7.
9. Sällström J, Carlström M, Olerud J, et al. High-protein-induced glomerular hyperfiltration is independent of the tubuloglomerular feedback mechanism and nitric oxide synthases. Am J Physiol Regul Integr Comp Physiol 2010;299:R1263-R1268.
10. Cirillo M, Lombardi C, Chiricone D, De Santo NG, Zanchetti A, Bilancio G. Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data. Nephrol Dial Transplant 2014;29:1733-40.
11. Ruilope LM, Casal MC, Praga M, et al. Additive antiproteinuric effect of converting enzyme inhibition and a low protein intake. J Am Soc Nephrol 1992;3:1307-11.
12. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-84.
13. Levey AS, Greene T, Beck GJ, et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 1999;10:2426-39.
14. Kasiske BL, Lakatua JD, Ma JZ, Louis TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998;31:954-61.
15. Haring B, Selvin E, Liang M, et al. Dietary protein sources and risk for incident chronic kidney disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Ren Nutr 2017;27:233-42.
16. Kaysen GA, Gambertoglio J, Jimenez I, Jones H, Hutchison FN. Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 1986;29: 572-7.
17. Maroni BJ, Staffeld C, Young VR, Manatunga A, Tom K. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. J Clin Invest 1997;99:2479-87.
18. D’Amico G, Gentile MG, Manna G, et al. Effect of vegetarian soy diet on hyper-lipidaemia in nephrotic syndrome. Lancet 1992;339:1131-4.
19. Weiner ID, Mitch WE, Sands JM. Urea and ammonia metabolism and the control of renal nitrogen excretion. Clin J Am Soc Nephrol 2015;10:1444-58.
20. Protein and amino acids. Washington, DC: National Academy of Sciences, Institute of Medicine, Food and Nutrition Board, 2005.
21. Berg AH, Drechsler C, Wenger J, et al. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med 2013;5:175ra29.
22. Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW. The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 2012;7:982-8.
23. Walser M, Hill S. Can renal replacement be deferred by a supplemented very low protein diet? J Am Soc Nephrol 1999; 10:110-6.
24. Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 2007; 49:569-80.
25. Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol 2016;27:2164-76.
26. Ko GJ, Obi Y, Tortorici AR, Kalantar-Zadeh K. Dietary protein intake and chronic kidney disease. Curr Opin Clin Nutr Metab Care 2017;20:77-85.
27. Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 2013;97:1163-77.
28. Wu HL, Sung JM, Kao MD, Wang MC, Tseng CC, Chen ST. Nonprotein calorie supplement improves adherence to low-protein diet and exerts beneficial responses on renal function in chronic kidney disease. J Ren Nutr 2013;23:271-6.
29. Paes-Barreto JG, Silva MI, Qureshi AR, et al. Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease? J Ren Nutr 2013;23:164-71.
30. Mente A, O’Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 2014;371:601-11.
31. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2013;4:CD004937.
32. O’Donnell M, Mente A, Yusuf S. Sodium intake and cardiovascular health. Circ Res 2015;116:1046-57.
33. Kwakernaak AJ, Krikken JA, Binnenmars SH, et al. Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial. Lancet Diabetes Endocrinol 2014;2:385-95.
34. McMahon EJ, Bauer JD, Hawley CM, et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol 2013; 24:2096-103.
35. Smyth A, Dunkler D, Gao P, et al. The relationship between estimated sodium and potassium excretion and subsequent renal outcomes. Kidney Int 2014;86:1205-12.
36. He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol 2016;27: 1202-12.
37. Mills KT, Chen J, Yang W, et al. Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA 2016;315:2200-10.
38. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 2011;305:1777-85.
39. Kovesdy CP, Lott EH, Lu JL, et al. Hypo-natremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012;125:677-84.
40. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73:391-8.
41. Sontrop JM, Dixon SN, Garg AX, et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 2013;37:434-42.
42. Palmer BF, Clegg DJ. Achieving the benefits of a high-potassium, paleolithic diet, without the toxicity. Mayo Clin Proc 2016;91:496-508.
43. Araki S, Haneda M, Koya D, et al. Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function. Clin J Am Soc Nephrol 2015;10: 2152-8.
44. Water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academy of Sciences, Institute of Medicine, Food and Nutrition Board, 2004.
45. Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 2010;56:338-47.
46. Chen Y, Sang Y, Ballew SH, et al. Race, serum potassium, and associations with ESRD and mortality. Am J Kidney Dis 2017; 70:244-51.
47. Khoueiry G, Waked A, Goldman M, et al. Dietary intake in hemodialysis patients does not reflect a heart healthy diet. J Ren Nutr 2011;21:438-47.
48. St-Jules DE, Goldfarb DS, Sevick MA. Nutrient non-equivalence: does restricting high-potassium plant foods help to prevent hyperkalemia in hemodialysis patients? J Ren Nutr 2016;26:282-7.
49. Sim JJ, Bhandari SK, Smith N, et al. Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 2013;126:311-8.
50. Gutiérrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-92.
51. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011;121:4393-408.
52. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:519-30.
53. Moorthi RN, Armstrong CL, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM. The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol 2014;40:582-91.
54. Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009;301:629-35.
55. Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 2011;6:620-9.
56. Tonelli M, Pannu N, Manns B. Oral phosphate binders in patients with kidney failure. N Engl J Med 2010;362:1312-24.
57. Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int 2012;81: 1116-22.
58. Bushinsky DA. Clinical application of calcium modeling in patients with chronic kidney disease. Nephrol Dial Transplant 2012;27:10-3.
59. Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2013; 83:959-66.
60. de Zeeuw D, Agarwal R, Amdahl M, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010;376:1543-51.
61. Powe CE, Evans MK, Wenger J, et al. Vitamin D–binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.
62. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int 2017;92:26-36.
63. Young VR, Pellett PL. Plant proteins in relation to human protein and amino acid nutrition. Am J Clin Nutr 1994;59:Suppl: 1203S-1212S.
64. Chen X, Wei G, Jalili T, et al. The associations of plant protein intake with all-cause mortality in CKD. Am J Kidney Dis 2016;67:423-30.
65. Sumida K, Molnar MZ, Potukuchi PK, et al. Constipation and incident CKD. J Am Soc Nephrol 2017;28:1248-58.
66. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-63.
67. Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int 2015;88:958-66.
68. Rossi M, Johnson DW, Xu H, et al. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 2015; 25:860-5.
69. Schulman G, Berl T, Beck GJ, et al. Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol 2015;26:1732-46.
70. Chiavaroli L, Mirrahimi A, Sievenpiper JL, Jenkins DJ, Darling PB. Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2015;69:761-8.
71. Salmean YA, Segal MS, Palii SP, Dahl WJ. Fiber supplementation lowers plasma p-cresol in chronic kidney disease patients. J Ren Nutr 2015;25:316-20.
72. Han E, Yun Y, Kim G, et al. Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. PLoS One 2016;11(5):e0154683.
73. Hood VL, Tannen RL. Protection of acid–base balance by pH regulation of acid production. N Engl J Med 1998;339:819-26.
74. Krapf R, Vetsch R, Vetsch W, Hulter HN. Chronic metabolic acidosis increases the serum concentration of 1,25-dihy-droxyvitamin D in humans by stimulating its production rate: critical role of acidosis-induced renal hypophosphatemia. J Clin Invest 1992;90:2456-63.
75. So R, Song S, Lee JE, Yoon HJ. The association between renal hyperfiltration and the sources of habitual protein intake and dietary acid load in a general population with preserved renal function: the KoGES Study. PLoS One 2016;11(11): e0166495.
76. Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int 2012; 81:86-93.
77. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009;20:2075-84.
78. Swaminathan S. Trace elements, toxic metals, and metalloids in kidney disease. In: Kopple JD, Massry S, Kalantar-Zadeh K, eds. Nutritional management of renal disease. 3rd ed. London: Academic Press of Elsevier, 2013:339-49.
79. Clase CM, Ki V, Holden RM. Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review. Semin Dial 2013;26:546-67.
80. Ishigami J, Grams ME, Naik RP, Coresh J, Matsushita K. Chronic kidney disease and risk for gastrointestinal bleeding in the community: the Atherosclerosis Risk in Communities (ARIC) Study. Clin J Am Soc Nephrol 2016;11:1735-43.
81. Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA Intern Med 2016;176:1443-50.
82. McCabe KM, Booth SL, Fu X, et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013;83:835-44.